Add to ORKGBeta-blockers Angiotensin receptor blockers Angiotensin-converting enzyme inhibitors A B S T R A C T Introduction and objectives: To compare acute myocardial infarction patients with or without congestive heart failure in the French FAST-MI registry. Methods: The French FAST-MI registry included 374 centers and 3059 patients over a 1-month period at the end of 2005, with 1-year follow-up. Among this population, patients with at least one congestive heart failure criterion constituted group 1 (n=1149; 37.5%) and were compared to patients withou
Background: The monitoring of healthcare quality indicators (HCQI) is a process of utmost importance...
Abstract: Underlying causes, risk factors, and precipitating causes of heart failure (HF) should be ...
Background: Congestive heart failure (CHF) is a rather prevalent condition with a high mortality rat...
Greater morbidity and mortality in acute myocardial in-farction is related to its occurrence in the ...
Aim: The aim of the study was to observe the epidemiology and pattern of fascicular block following ...
Background: In July 2003 the National Institute of Clinical Excellence (NICE) issued guidelines on t...
Background: Heart failure (HF) is one of the leading causes of hospitalization in adults in Brazil. ...
Background: Cardiovascular disease is the leading cause of mortality in the western world and its tr...
objective: Describe clinical characteristics of patients (P) admitted to hospital with suspected acu...
Objective: Heart failure is frequently a serious complication of acute myocardial infarction (AMI). ...
a portion of reimbursement to hospitals be contingent on public reporting of performance measures fo...
Angiotensin-converting enzyme (ACE) inhibitors are currently considered the mainstay of treatment fo...
Background: Heart failure (HF) is a syndrome that leads to poor outcome in advanced forms. The neuro...
Background: The effects of modern therapy on functional recovery after acute myocardial infarction (...
CONTEXT: Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of myocardial infarction (MI...
Background: The monitoring of healthcare quality indicators (HCQI) is a process of utmost importance...
Abstract: Underlying causes, risk factors, and precipitating causes of heart failure (HF) should be ...
Background: Congestive heart failure (CHF) is a rather prevalent condition with a high mortality rat...
Greater morbidity and mortality in acute myocardial in-farction is related to its occurrence in the ...
Aim: The aim of the study was to observe the epidemiology and pattern of fascicular block following ...
Background: In July 2003 the National Institute of Clinical Excellence (NICE) issued guidelines on t...
Background: Heart failure (HF) is one of the leading causes of hospitalization in adults in Brazil. ...
Background: Cardiovascular disease is the leading cause of mortality in the western world and its tr...
objective: Describe clinical characteristics of patients (P) admitted to hospital with suspected acu...
Objective: Heart failure is frequently a serious complication of acute myocardial infarction (AMI). ...
a portion of reimbursement to hospitals be contingent on public reporting of performance measures fo...
Angiotensin-converting enzyme (ACE) inhibitors are currently considered the mainstay of treatment fo...
Background: Heart failure (HF) is a syndrome that leads to poor outcome in advanced forms. The neuro...
Background: The effects of modern therapy on functional recovery after acute myocardial infarction (...
CONTEXT: Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of myocardial infarction (MI...
Background: The monitoring of healthcare quality indicators (HCQI) is a process of utmost importance...
Abstract: Underlying causes, risk factors, and precipitating causes of heart failure (HF) should be ...
Background: Congestive heart failure (CHF) is a rather prevalent condition with a high mortality rat...